Amedisys Reports Third Quarter 2019 Financial Results and Updates 2019 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys (AMED) Tops Q3 EPS by 26c
October 29, 2019 4:09 PM EDTAmedisys (NASDAQ: AMED) reported Q3 EPS of $1.15, $0.26 better than the analyst estimate of $0.89. Revenue for the quarter came in at $494.6 million versus the consensus estimate of $494.16 million.
GUIDANCE:
Amedisys sees FY2019 EPS of $4.32-$4.39, versus the consensus of $4.15. Amedisys sees... More



